Jak kinase activity is required for lymphoma invasion and metastasis

Oncogene

Volumn 23, Issue 39, 2004, Pages 6647-6653

  Opdam, Frank J M ^a   Kamp, Marga ^a   De Bruijn, Rosalie ^a   Roos, Ed ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Adhesion; CXCR4 migration; G protein; Integrin

Indexed keywords

4 (4 HYDROXYANILINO) 6,7 DIMETHOXYQUINAZOLINE; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; ENZYME INHIBITOR; GROWTH FACTOR; INTEGRIN; JANUS KINASE; JANUS KINASE 2; JANUS KINASE INHIBITOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; T CELL LYMPHOMA; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

JANUS;

ANIMALS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOMA; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN-TYROSINE KINASES; RECEPTORS, CXCR4;

EID: 4444329079     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207887     Document Type: Article

References (33)

1. Bromberg J. (2002). J. Clin. Invest., 109, 1139-1142.
2. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE. (1999). Cell, 98, 295-303.
3. Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT, Bernard O and Ghysdael J. (2000). Blood, 95, 3891-3899.
4. Chan AC and Shaw AS. (1995). Curr. Opin. Immunol, 8, 394-401.
5. Didichenko SA, Tilton B, Hemmings BA, Ballmer-Hofer K and Thelen M. (1996). Curr. Biol, 10, 1271-1278.
6. Döbbeling U, Dummer R, Laine E, Potoczna N, Qin JZ and Burg G. (1998). Blood, 92, 252-258.
7. Galm O, Yoshikawa H, Esteller M, Osieka R and Herman JG. (2003). Blood, 101, 2784-2788.
8. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A and Jove R. (2001). Oncogene, 3, 2499-2513.
9. Hou SX, Zheng Z, Chen X and Perrimon N. (2002). Dev. Cell, 3, 765-768.
10. La Rivière, G, Klein Gebbinck JW, Schipper CA, Mooi WJ and Roos E. (1993). J. Leukoc. Biol., 53, 381-389.
11. La Rivière G, Schipper C, Collard JG and Roos E. (1988). Cancer Res., 48, 3405-3410.
12. Leonard WJ and O'Shea JJ. (1998). Annu. Rev. Immunol., 16, 293-322.
13. Luo H, Rose P, Barber D, Hanratty WP, Lee S, Roberts TM, D'Andrea AD and Dearolf CR. (1997). Mol. Cell. Biol., 17, 1562-1571.
14. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A and Roifman CM. (1996). Nature, 379, 645-648.
15. Michiels F, Van der Kammen RA, Janssen L, Nolan GP and Collard JG. (2000). Methods Enzymol, 325, 295-302.
16. Nguyen MH, Ho JM, Beattie BK and Barber DL. (2001). J. Biol Chem., 276, 32704-32713.
17. Peelers P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H and Marynen P. (1997). Blood, 90, 2535-2540.
18. Roland J, Murphy BJ, Ahr B, Robert-Hebmann V, Delauzun V, Nye KE, Devaux C and Biard-Piechaczyk M. (2003). Blood, 101, 399-406.
19. Roossien FF, Bikker A, De Rijk D and Roos E. (1989). J. Cell Biol., 108, 1979-1985.
20. Saharinen P and Silvennoinen O. (2002). J. Biol. Chem., 277, 47954-47963.
21. Saharinen P, Takaluoma K and Silvennoinen O. (2000). Mol. Biol. Cell., 20, 3387-3395.
22. Schuringa JJ, Wierenga AT, Kruijer W and Vellenga E. (2000). Blood, 95, 3765-3770.
23. Silver DL and Montell DJ. (2001). Cell, 107, 831-841.
24. Soede RD, Driessens MH, Ruuls-Van Stalle L, Van Hulten PE, Brink A and Roos E. (1999). J. Immunol., 163, 4253-4261.
25. Soede RD, Wijnands YM, Van Kouteren-Cobzaru I and Roos E. (1998). J. Cell Biol., 142, 1371-1379.
26. Soede RD, Zeelenberg IS, Wijnands YM, Kamp M and Roos E. (2001). J. Immunol., 166, 4293-4301.
27. 3 Soriano SF, Serrano A, Hernanz-Falcon P, De Ana MA, Monterrubio M, Martinez-A C, Rodriguez-Frade JM and Mellado M. (2003). Eur. J. Immunol., 33, 1328-1333.
28. Takeshita T, Arita T, Higuchi M, Asao H, Endo K, Kuroda H, Tanaka N, Murata K, Ishii N and Sugamura K. (1997). Immunity, 6, 449-457.
29. Tibbles HE, Vassilev A, Wendorf H, Schonhoff D, Zhu D, Lorenz D, Waurzyniak B, Liu XP and Uckun FM. (2001). J. Biol. Chem., 276, 17815-17822.
30. Vila-Coro AJ, Rodriguez-Frade JM, De Ana AM, Moreno-Ortiz MC, Martinez-A C and Mellado M. (1999). FASEB J., 13, 1699-1710.
31. Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE and Arlinghaus RB. (2001). Oncogene, 20, 6188-6195.
32. Zeelenberg IS, Ruuls-Van Stalle L and Roos E. (2001). J. Clin. Invest., 108, 269-277.
33. Zhang XF, Wang JF, Matczak E, Proper J and Groopman JE. (2001). Blood, 97, 3342-3348.